190892
Last Update Posted: 2007-01-26
Recruiting has ended
All Genders accepted | 18 Years-65 Years |
120 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Olanzapine Plus Carbamazepine in the Treatment of Bipolar I Mania
This trial will assess any efficacious benefit and any safety issues associated with the concomitant use of olanzapine and carbamazepine for the treatment of patients with bipolar I disorder, manic or mixed episodes
Eligibility
Relevant conditions:
Bipolar Disorder
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov